Want to join the conversation?
During 2015, $MYL recorded a $97.4MM net gain for litigation settlements vs. a net charge of $47.9MM in the prior year. The gain in 2015 was primarily related to the settlement of the Paroxetine CR matter with $GSK for approx. $113MM and the settlement of certain antitrust matters, partially offset by the settlement of patent infringement matters.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?